212 related articles for article (PubMed ID: 27647769)
1. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial.
Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Rojanavanich V; Phothong W; Manuskiatti W
J Cosmet Dermatol; 2016 Dec; 15(4):452-457. PubMed ID: 27647769
[TBL] [Abstract][Full Text] [Related]
2. Intradermal injection of incobotulinumtoxinA for face lifting.
Wanitphakdeedecha R; Nokdhes YN; Patthamalai P; Yan C; Techapichetvanich T; Phothong W; Eimpunth S; Manuskiatti W
Dermatol Ther; 2020 Nov; 33(6):e13944. PubMed ID: 32614987
[TBL] [Abstract][Full Text] [Related]
3. Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
Wanitphakdeedecha R; Yan C; Apinuntham C; Rojanavanich V; Cembrano KAG; Eimpunth S; Manuskiatti W
Dermatol Ther (Heidelb); 2020 Aug; 10(4):779-789. PubMed ID: 32591944
[TBL] [Abstract][Full Text] [Related]
4. Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians.
Sirithanabadeekul P; Lapsomboonsiri S; Rungjang A; Thanasarnaksorn W
J Cosmet Dermatol; 2018 Jun; 17(3):355-360. PubMed ID: 29878718
[TBL] [Abstract][Full Text] [Related]
5. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
Allen SB; Goldenberg NA
Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
[TBL] [Abstract][Full Text] [Related]
6. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study.
Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Lektrakul N; Manuskiatti W
J Dermatolog Treat; 2017 Aug; 28(5):443-446. PubMed ID: 27884065
[TBL] [Abstract][Full Text] [Related]
8. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation.
Zhu J; Ji X; Xu Y; Liu J; Miao YY; Zhang JA; Luo D; Zhou BR
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27862727
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
Elridy AS; Zaki RGE; Elshinawy RF
Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
Jochim A; Meindl T; Mantel T; Zwirner S; Zech M; Castrop F; Haslinger B
J Neurol; 2019 Aug; 266(8):1879-1886. PubMed ID: 31049731
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
14. Eighteen-point abobotulinum toxin a upper face rejuvenation: an eye plastic perspective on 845 subjects.
Kashkouli MB; Amani A; Jamshidian-Tehrani M; Yousefi S; Jazayeri AA
Ophthalmic Plast Reconstr Surg; 2014; 30(3):219-24. PubMed ID: 24481513
[TBL] [Abstract][Full Text] [Related]
15. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
16. Comparing the clinical attributes of abobotulinumtoxinA and onabotulinumtoxinA utilizing a novel contralateral Frontalis model and the Frontalis Activity Measurement Standard.
Nestor MS; Ablon GR
J Drugs Dermatol; 2011 Oct; 10(10):1148-57. PubMed ID: 21968665
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Microneedle Thickness on Pain During Minimally Invasive Facial Procedures: A Clinical Study.
Sezgin B; Ozel B; Bulam H; Guney K; Tuncer S; Cenetoglu S
Aesthet Surg J; 2014 Jul; 34(5):757-65. PubMed ID: 24787992
[TBL] [Abstract][Full Text] [Related]
18. A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging.
Sapra P; Demay S; Sapra S; Khanna J; Mraud K; Bonadonna J
J Clin Aesthet Dermatol; 2017 Feb; 10(2):34-44. PubMed ID: 28367260
[No Abstract] [Full Text] [Related]
19. Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.
Atwa EM; Nasr MM; Ebrahim HM
J Clin Aesthet Dermatol; 2020 Dec; 13(12):22-26. PubMed ID: 33488914
[No Abstract] [Full Text] [Related]
20. Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement.
Park JY; Cho SI; Hur K; Lee DH
J Drugs Dermatol; 2021 Jan; 20(1):49-54. PubMed ID: 33400411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
